Mitä "Tyhjennä" tarkoittaa?
Eläin ei kanna mutaatiota. Se ei kehitä tautia eikä anna sitä eteenpäin.
Discover the Australian Labradoodle Dystrophinopathy (DMD-AL) DNA test, an essential tool for dog breeders and owners. This genetic test identifies the presence of mutations linked to DMD-AL, a condition affecting muscle strength and health in Australian Labradoodles. Early detection through DMD-AL testing can help prevent the onset of symptoms and guide responsible breeding practices. Ensure your furry friend’s well-being by opting for this crucial DNA test. By understanding your dog’s genetic profile, you can make informed decisions that promote a healthier, happier life. Trust the DMD-AL DNA test for a proactive approach to your Australian Labradoodle's health. Take action today to safeguard your pet's future!
Duchenne Muscular Dystrophy In Australian Labradoodle
The Australian Labradoodle Dystrophinopathy (DMD-AL) is a genetic condition affecting Australian Labradoodles, characterized by a deficiency in dystrophin, a protein essential for muscle function. This DNA test helps identify carriers of the mutation responsible for the disease, allowing breeders to make informed decisions and reduce its prevalence. Early detection through genetic testing can lead to better management strategies and ensure healthier breeding practices. Responsible breeding can significantly improve the quality of life for affected dogs, promoting overall breed health. Owners and breeders are encouraged to utilize this test to support the wellbeing of future generations of Australian Labradoodles.
Tämä DNA-testi sisältyy pakettiin alkaen Basic — ja se on myös osa paketteja Basic, Standard, Advanced, Complete.
Katso DNA-testipaketit →Australian Labradoodle Dystrophinopathy (DMD-AL) is a genetic condition that affects the muscle function of Australian Labradoodles. This disorder is caused by mutations in the dystrophin gene, which is essential for maintaining the integrity of muscle fibers. As a result, affected dogs may experience progressive muscle weakness and degeneration, leading to significant mobility issues over time.
Dogs with DMD-AL often exhibit a range of symptoms that can vary in severity. Common signs include difficulty in walking, reluctance to engage in physical activities, and noticeable muscle wasting. As the disease progresses, owners may observe a decline in the dog’s overall stamina and strength, which can severely impact their quality of life.
Diagnosis of DMD-AL typically involves a combination of clinical evaluation and genetic testing. Veterinarians may conduct physical examinations to assess muscle strength and function. Additionally, DNA testing can confirm the presence of the specific mutations associated with DMD-AL, providing a definitive diagnosis.
DNA testing for DMD-AL is crucial for breeders and dog owners alike. For breeders, it helps in making informed decisions to avoid producing affected puppies, thus contributing to the overall health of the breed. For owners, knowing whether their dog is a carrier or affected allows for better management of the condition and planning for future care needs.
Currently, there is no cure for DMD-AL, but management strategies can help improve the quality of life for affected dogs. This may include physical therapy, nutritional support, and regular veterinary check-ups to monitor the progression of the disease. Owners should work closely with their veterinarians to develop a tailored management plan that addresses the specific needs of their dog.
Understanding Australian Labradoodle Dystrophinopathy (DMD-AL) is essential for responsible dog ownership and breeding practices. DNA testing plays a vital role in identifying affected and carrier dogs, enabling proactive measures to promote the health and well-being of this beloved breed. Awareness and education about DMD-AL can significantly enhance the lives of both dogs and their owners.
Eläin ei kanna mutaatiota. Se ei kehitä tautia eikä anna sitä eteenpäin.
Ei. Eläin on yleensä terve, mutta voi välittää mutaation sen jälkeläisiä.
Se sisältää kaksi mutatoitua kopiota. Kliinisiä oireita odotetaan riippuen tauti. Sitä ei pidä kasvattaa.
Jotkut sairaudet ovat sukupuoleen liittyviä, joten niiden ilmeneminen vaihtelee riippuen eläimen sukupuoli.
This DNA test detects the mutation associated with Australian Labradoodle Dystrophinopathy (DMD) in order to identify clear, carrier, or at-risk animals.
DNA-testaus auttaa kasvattajia suunnittelemaan turvallisempia pariutuksia ja vähentämään mutaation siirtymisen riskiä jälkeläisiin.
The inheritance mode reported for this test is X-Linked Recessive.
This test analyses the mutation DMD c.2668C>T.
Ei välttämättä. Tulkinta riippuu perinnöllisyysmallista ja tuloksena olevasta genotyypistä.
Shrader Stephanie M, Jung SeungWoo, Denney Thomas S, Smith Bruce F. Characterization of Australian Labradoodle dystrophinopathy. Neuromuscul Disord. 2018 Nov;28(11):927-937. doi: 10.1016/j.nmd.2018.08.008. Epub 2018 Aug 29.
Sinun yksityisyytesi, sinun valintasi
Käytämme välttämättömiä evästeitä verkkosivuston ylläpitämiseen. Valinnaiset evästeet (kuten upotetut sisällöntarjoajat) ovat oletusarvoisesti poissa käytöstä ja ovat käytössä vain, jos hyväksyt. Voit muuttaa valintaasi milloin tahansa käyttämällä "Evästeet" -painiketta.
Vaaditaan ydinominaisuuksien ja suojauksen vuoksi. Aina käytössä.
Parantaa ominaisuuksia, kuten asetusten tallentamista tai ei-mainonnan upottamista.
Auttaa meitä ymmärtämään sivuston käyttöä. Ei käytössä oletuksena.
Mainonta/seuranta eri sivustoilla (jotkut video-/karttojen upotukset). Ei käytössä oletuksena.